BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32975180)

  • 21. Qualitative and semi-quantitative comparison of an rK39 strip test and direct agglutination test for detection of anti-Leishmania donovani antibodies in the Sudan.
    Mansour D; Abass EM; Mahamoud A; el Harith A
    Iran J Immunol; 2009 Dec; 6(4):208-15. PubMed ID: 20054109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis.
    Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis: an early report from eastern India.
    Goswami RP; Goswami RP; Das S; Ray Y; Rahman M
    J Postgrad Med; 2012; 58(3):180-4. PubMed ID: 23023349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms.
    Bhattacharyya T; Boelaert M; Miles MA
    PLoS Negl Trop Dis; 2013; 7(2):e2057. PubMed ID: 23469296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.
    Mollett G; Bremer Hinckel BC; Bhattacharyya T; Marlais T; Singh OP; Mertens P; Falconar AK; El-Safi S; Sundar S; Miles MA
    Clin Infect Dis; 2019 Sep; 69(7):1130-1135. PubMed ID: 30541022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rK39 testing in guiding treatment initiation and outcome in patients with visceral leishmaniasis in Ethiopia: A prospective cohort study.
    Hagos DG; Kebede Y; Abdulkader M; Nigus E; Gessesse Arefaine Z; Nega G; Schallig HDF; Wolday D
    PLoS One; 2021; 16(6):e0253303. PubMed ID: 34125865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain.
    Ejazi SA; Ghosh S; Saha S; Choudhury ST; Bhattacharyya A; Chatterjee M; Pandey K; Das VNR; Das P; Rahaman M; Goswami RP; Rai K; Khanal B; Bhattarai NR; Deepachandi B; Siriwardana YD; Karunaweera ND; deBrito MEF; Gomes YM; Nakazawa M; Costa CHN; Adem E; Yeshanew A; Melkamu R; Fikre H; Hurissa Z; Diro E; Carrillo E; Moreno J; Ali N
    Sci Rep; 2019 Jul; 9(1):9932. PubMed ID: 31289323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in Ethiopia.
    Kassa M; Abdellati S; Cnops L; Bremer Hinckel BC; Yeshanew A; Hailemichael W; Vogt F; Adriaensen W; Mertens P; Diro E; van Griensven J; Van den Bossche D
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008963. PubMed ID: 33382690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochromatographic rK39 strip test in the serodiagnosis of visceral leishmaniasis in Tunisia.
    Saghrouni F; Gaïed-Meksi S; Fathallah A; Amri F; Ach H; Guizani I; Ben Saïd M
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1273-8. PubMed ID: 19070876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological studies on rK39 negative Visceral Leishmaniasis in an endemic focus of Leishmania donovani induced Cutaneous Leishmaniasis.
    Deepachandi B; Weerasinghe S; Soysa P; Chatterjee M; Siriwardana Y
    Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115873. PubMed ID: 36543026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel 12.6-kDa protein of Leishmania donovani for the diagnosis of Indian visceral leishmaniasis.
    Kumar D; Kumar S; Chakravarty J; Sundar S
    Vector Borne Zoonotic Dis; 2011 Oct; 11(10):1359-64. PubMed ID: 21923256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis.
    Badaró R; Benson D; Eulálio MC; Freire M; Cunha S; Netto EM; Pedral-Sampaio D; Madureira C; Burns JM; Houghton RL; David JR; Reed SG
    J Infect Dis; 1996 Mar; 173(3):758-61. PubMed ID: 8627048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection.
    Sinha PK; Bimal S; Pandey K; Singh SK; Ranjan A; Kumar N; Lal CS; Barman SB; Verma RB; Jeyakumar A; Das P; Bhattacharya M; Sur D; Bhattacharya SK
    Ann Trop Med Parasitol; 2008 Mar; 102(2):119-25. PubMed ID: 18318933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.
    Banu SS; Meyer W; Ahmed BN; Kim R; Lee R
    Trans R Soc Trop Med Hyg; 2016 May; 110(5):286-93. PubMed ID: 27198212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.
    Dhom-Lemos L; Viana AG; Cunha JLR; Cardoso MS; Mendes TAO; Pinheiro GRG; Siqueira WF; Lobo FP; Teles LF; Bueno LL; Guimarães-Carvalho SF; Bartholomeu DC; Fujiwara RT
    PLoS One; 2019; 14(1):e0211719. PubMed ID: 30703138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal reservoirs of visceral leishmaniasis in India.
    Singh N; Mishra J; Singh R; Singh S
    J Parasitol; 2013 Feb; 99(1):64-7. PubMed ID: 22765517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B; Rijal S; Ostyn B; Picado A; Gidwani K; Menten J; Jacquet D; Lejon V; Chappuis F; Boelaert M
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India.
    Vaish M; Bhatia A; Reed SG; Chakravarty J; Sundar S
    Clin Microbiol Infect; 2012 Jan; 18(1):81-5. PubMed ID: 21722262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.